Company research
SkinHealth Systems Inc.
CIK 1818093Updated Sep 24, 2026
SecuritySKIN · NASDAQ · equity
Name history
Beauty Health Co · through Apr 20, 2026Vesper Healthcare Acquisition Corp. · through Apr 30, 2021
SKIN price & chart
Loading TradingView…
NASDAQ:SKIN on TradingView ↗About the company
SkinHealth Systems (NASDAQ: SKIN) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial™, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus™ microneedling and HydraScalp™ with Keravive™, SkinHealth Systems combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide. Learn more at skinhealthsystems.com or follow us on LinkedIn. Local providers can be found at hydrafacial.com/find-a-hydrafacialist.
In the news
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
4 filing
DEFA14A filing
DEF 14A filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 499,803,000Source | 685,683,000Source | 929,113,000Source | 1,008,907,000Source |
| GoodwillUSD | 126,621,000Source | 123,499,000Source | 125,818,000Source | 124,593,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | 523,025,000Source | 568,197,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 21,741,000Source | 27,643,000Source | 54,697,000Source | 76,494,000Source |
| Inventory, NetUSD | 48,012,000Source | 69,113,000Source | 91,321,000Source | 116,430,000Source |
| Assets, CurrentUSD | 309,517,000Source | 477,124,000Source | 698,252,000Source | 789,099,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 5,395,000Source | 9,487,000Source | 28,877,000Source | 26,698,000Source |
| Operating Lease, Right-of-Use AssetUSD | 11,570,000Source | 13,590,000Source | 12,120,000Source | 15,637,000Source |
| Other Assets, NoncurrentUSD | 11,869,000Source | 14,086,000Source | 16,043,000Source | 14,193,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 438,747,000Source | 633,880,000Source | 869,723,000Source | 837,431,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | — | 0Source |
| Common Stock, Value, IssuedUSD | 13,000Source | 12,000Source | 12,000Source | 14,000Source |
| Additional Paid in CapitalUSD | 579,961,000Source | 566,709,000Source | 541,281,000Source | 550,320,000Source |
| Retained Earnings (Accumulated Deficit)USD | -517,484,000Source | -507,965,000Source | -478,867,000Source | -374,328,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,434,000Source | -6,953,000Source | -3,036,000Source | -4,530,000Source |
| Stockholders' Equity Attributable to ParentUSD | 61,056,000Source | 51,803,000Source | 59,390,000Source | 171,476,000Source |
| Liabilities and EquityUSD | 499,803,000Source | 685,683,000Source | 929,113,000Source | 1,008,907,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 186,275,000Source | 68,152,000Source | 115,008,000Source | 73,115,000Source |
| Operating Lease, Liability, CurrentUSD | 5,128,000Source | 5,147,000Source | 4,598,000Source | 4,958,000Source |
| Accounts Payable, CurrentUSD | 15,631,000Source | 21,941,000Source | 44,768,000Source | 30,335,000Source |
| Operating Lease, Liability, NoncurrentUSD | 9,238,000Source | 10,813,000Source | 9,319,000Source | 12,689,000Source |
| Deferred Income Tax Liabilities, NetUSD | 393,000Source | 396,000Source | 702,000Source | 2,011,000Source |
| Other Liabilities, NoncurrentUSD | 2,410,000Source | 1,833,000Source | 2,767,000Source | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 15,384,000Source | 20,002,000Source | 19,846,000Source | 15,183,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | 171,000Source | 1,196,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 14,824,000Source | 26,696,000Source | 22,544,000Source | 28,495,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -5,162,000Source | -20,804,000Source | -16,520,000Source | 32,025,000Source |
| Increase (Decrease) in InventoriesUSD | -15,792,000Source | 10,500,000Source | 22,617,000Source | 82,097,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | 15,783,000Source | 1,606,000Source |
| Deferred Income Tax Expense (Benefit)USD | 1,879,000Source | -3,595,000Source | -5,816,000Source | -1,787,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 37,485,000Source | 16,134,000Source | 21,750,000Source | -106,600,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -5,163,000Source | -6,794,000Source | -31,507,000Source | -18,869,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | 0Source | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | 303,000Source | 756,000Source | 3,825,000Source | 10,847,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 1,572,000Source | 1,957,000Source | 3,234,000Source | 927,000Source |
| Payments for Repurchase of Common StockUSD | 0Source | 0Source | 30,155,000Source | 160,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -174,926,000Source | -158,341,000Source | -37,448,000Source | -205,242,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | 0Source | -302,000Source | 0Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 232,673,000Source | 370,063,000Source | 523,025,000Source | 568,197,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 14,440,000Source | 8,014,000Source | 9,375,000Source | 9,818,000Source |
| Income Taxes Paid, NetUSD | 3,950,000Source | 2,801,000Source | 2,269,000Source | -1,339,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 5,214,000Source | -3,961,000Source | 2,033,000Source | -2,978,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 22,544,000Source | 28,495,000Source |
| Amortization of Deferred ChargesUSD | — | — | — | 14,852,000Source |
| Amortization of Debt Issuance CostsUSD | 3,636,000Source | 3,319,000Source | — | — |
| Amortization of Intangible AssetsUSD | 16,988,000Source | 19,537,000Source | 20,907,000Source | 14,852,000Source |
| Capitalized Computer Software, AmortizationUSD | — | — | — | 0Source |
| DepreciationUSD | 3,848,000Source | 9,940,000Source | 11,332,000Source | 7,164,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 5,819,000Source | -4,638,000Source | 2,385,000Source | -3,164,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | — | — | — | -2,410,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | -5,239,000Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | — | — | — | -2,500,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | -2,000,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | 18,089,000Source | 33,411,000Source | — | — |
| General and Administrative ExpenseUSD | 117,949,000Source | 125,463,000Source | 131,432,000Source | 106,100,000Source |
| GoodwillUSD | 126,621,000Source | 123,499,000Source | 125,818,000Source | 124,593,000Source |
| Income Tax Expense (Benefit)USD | 3,581,000Source | -452,000Source | -1,773,000Source | 648,000Source |
| InterestExpenseNonoperatingUSD | 19,326,000Source | 10,412,000Source | — | — |
| Inventory Write-downUSD | 7,219,000Source | 28,041,000Source | 18,272,000Source | — |
| Investment Income, InterestUSD | 8,954,000Source | 16,644,000Source | 23,173,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | -9,519,000Source | -29,098,000Source | -100,116,000Source | 44,384,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -9,519,000Source | -29,098,000Source | -100,116,000Source | 44,384,000Source |
| Operating ExpensesUSD | 217,167,000Source | 250,070,000Source | 286,030,000Source | 274,620,000Source |
| Other Nonoperating Income (Expense)USD | 18,931,000Source | 33,563,000Source | 5,200,000Source | -1,650,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 300,790,000Source | 334,294,000Source | 397,991,000Source | 365,876,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -20,803,000Source | -67,774,000Source | -130,917,000Source | -24,280,000Source |
| Other Nonoperating Income (Expense)USD | 18,931,000Source | 33,563,000Source | 5,200,000Source | -1,650,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -5,938,000Source | -29,550,000Source | -101,889,000Source | 45,032,000Source |
| Income Tax Expense (Benefit)USD | 3,581,000Source | -452,000Source | -1,773,000Source | 648,000Source |
| Net Income (Loss) Attributable to ParentUSD | -9,519,000Source | -29,098,000Source | -100,116,000Source | 44,384,000Source |
| Earnings Per Share, BasicUSD per share | -0.08Source | -0.23Source | -0.76Source | 0.3Source |
| Earnings Per Share, DilutedUSD per share | -0.16Source | -0.36Source | -0.76Source | -0.23Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 126,378,509Source | 123,827,372Source | 131,680,605Source | 147,554,090Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 135,798,202Source | 142,492,575Source | 131,680,605Source | 148,506,312Source |
| Interest Expense (non-operating)USD | 19,326,000Source | 10,412,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 16,988,000Source | 19,537,000Source | 20,907,000Source | 14,852,000Source |
| Capitalized Computer Software, AmortizationUSD | — | — | — | 0Source |
| Current Income Tax Expense (Benefit)USD | 1,702,000Source | 3,143,000Source | 4,043,000Source | 2,435,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 5,819,000Source | -4,638,000Source | 2,385,000Source | -3,164,000Source |
| General and Administrative ExpenseUSD | 117,949,000Source | 125,463,000Source | 131,432,000Source | 106,100,000Source |
| Gross ProfitUSD | 196,364,000Source | 182,296,000Source | 155,113,000Source | 250,340,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -12,462,000Source | -28,332,000Source | -104,161,000Source | 43,641,000Source |
| Interest ExpenseUSD | — | — | 13,649,000Source | — |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | — | -13,392,000Source |
| Interest Income, OtherUSD | — | — | — | 9,175,000Source |
| Investment Income, InterestUSD | 8,954,000Source | 16,644,000Source | 23,173,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -9,519,000Source | -29,098,000Source | -100,116,000Source | 44,384,000Source |
| Operating ExpensesUSD | 217,167,000Source | 250,070,000Source | 286,030,000Source | 274,620,000Source |
| Research and Development ExpenseUSD | 5,628,000Source | 6,296,000Source | 10,102,000Source | 8,444,000Source |
| Selling and Marketing ExpenseUSD | 93,590,000Source | 118,311,000Source | 144,496,000Source | 160,076,000Source |
Filing attachments
ex991-2026q2xearnings.htm · 8-K · 2026-08-06
EX-99.1 2 ex991-2026q2xearnings.htm EX-99.1 Document Exhibit 99.1 SkinHealth Systems Reports Second Quarter 2026 Financial Results Long Beach, Calif., August 6, 2026 - SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2026 (“Q2 2026”). "Our second quarter results reflect continued sales pressure, while adjusted EBITDA came in well above our guidance ra…
Read attachment ↗ex991-2026q1xearnings.htm · 8-K · 2026-05-07
EX-99.1 2 ex991-2026q1xearnings.htm EX-99.1 Document Exhibit 99.1 SkinHealth Systems Reports First Quarter 2026 Financial Results Long Beach, Calif., May 7, 2026 - SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 (“Q1 2026”). “First quarter results reflect the strength of the business. We delivered revenue within our guidance range, significantly…
Read attachment ↗ex991-corporaterebrandpres.htm · 8-K · 2026-04-22
EX-99.1 5 ex991-corporaterebrandpres.htm EX-99.1 Document The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform The Company will continue trading on the Nasdaq Capital Market under the ticker symbol “SKIN” LONG BEACH, Calif. - (GLOBE NEWSWIRE) - April 22, 2026 - The Beauty Health Company (NASDAQ: SKIN) today announced a corporate rebrand to SkinHealth Systems Inc., marking its …
Read attachment ↗ex992-bodpressrelease4x22x.htm · 8-K · 2026-04-22
EX-99.2 6 ex992-bodpressrelease4x22x.htm EX-99.2 Document SkinHealth Systems Inc. Appoints Three New Independent Directors to Board Kenneth Tripp, Dr. Sachin Shridharani, and E. Scott Beattie bring deep expertise in medical devices, aesthetic medicine, and global consumer brands Long Beach, CA, April 22, 2026 - SkinHealth Systems Inc. (formerly The Beauty Health Company; Nasdaq: SKIN), a global medical aesthetics company, today announced the appointment of three new independent directors …
Read attachment ↗ex991-2025q4xearnings.htm · 8-K · 2026-03-12
EX-99.1 2 ex991-2025q4xearnings.htm EX-99.1 Document Exhibit 99.1 BeautyHealth Reports Full Year and Fourth Quarter 2025 Financial Results Long Beach, Calif., March 12, 2026 - The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31, 2025 (“Q4 2025”). "Our fourth quarter results reflects meaningful structural progress in margins, profitability, a…
Read attachment ↗ex991-2025q3xearnings.htm · 8-K · 2025-11-06
EX-99.1 2 ex991-2025q3xearnings.htm EX-99.1 Document Exhibit 99.1 BeautyHealth Reports Third Quarter 2025 Financial Results Long Beach, Calif., November 6, 2025 - The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2025 (“Q3 2025”). “Our third-quarter results reflect disciplined execution and the continued strengthening of BeautyHealth’s foundation,” sai…
Read attachment ↗